Volume 128, Issue 8 pp. 1783-1790
Broncho-Esophagology

The effects of concurrent chemoradiation therapy to the base of tongue in a preclinical model

Peter A. Benedict BA

Peter A. Benedict BA

Department of Otolaryngology–Head and Neck Surgery, New York University Voice Center, New York University School of Medicine, New York, New York

Search for more papers by this author
Ryan Ruiz MD

Ryan Ruiz MD

Department of Otolaryngology–Head and Neck Surgery, New York University Voice Center, New York University School of Medicine, New York, New York

Search for more papers by this author
Avanti Verma MD

Avanti Verma MD

Department of Otolaryngology–Head and Neck Surgery, New York University Voice Center, New York University School of Medicine, New York, New York

Search for more papers by this author
Gregory R. Dion MD

Gregory R. Dion MD

Department of Otolaryngology–Head and Neck Surgery, New York University Voice Center, New York University School of Medicine, New York, New York

Department of Otolaryngology–Head and Neck Surgery, Brooke Army Medical Center, Fort Sam Houston, Texas, U.S.A.

Search for more papers by this author
Philmo Oh MD, PhD

Philmo Oh MD, PhD

Department of Radiation Oncology, New York University School of Medicine, New York, New York

Search for more papers by this author
Binhuan Wang PhD

Binhuan Wang PhD

Department of Population Heath, Division of Biostatistics, New York University School of Medicine, New York, New York

Search for more papers by this author
Omar H. Ahmed MD

Omar H. Ahmed MD

Department of Otolaryngology–Head and Neck Surgery, New York University Voice Center, New York University School of Medicine, New York, New York

Search for more papers by this author
Nao Hiwatashi MD, PhD

Nao Hiwatashi MD, PhD

Department of Otolaryngology–Head and Neck Surgery, New York University Voice Center, New York University School of Medicine, New York, New York

Search for more papers by this author
Renjie Bing MD

Renjie Bing MD

Department of Otolaryngology–Head and Neck Surgery, New York University Voice Center, New York University School of Medicine, New York, New York

Search for more papers by this author
Kristen Victor BS

Kristen Victor BS

Department of Otolaryngology–Head and Neck Surgery, New York University Voice Center, New York University School of Medicine, New York, New York

Search for more papers by this author
Kenneth S. Hu MD

Kenneth S. Hu MD

Department of Radiation Oncology, New York University School of Medicine, New York, New York

Search for more papers by this author
Aaron Johnson PhD

Aaron Johnson PhD

Department of Otolaryngology–Head and Neck Surgery, New York University Voice Center, New York University School of Medicine, New York, New York

Search for more papers by this author
Ryan C. Branski PhD

Corresponding Author

Ryan C. Branski PhD

Department of Otolaryngology–Head and Neck Surgery, New York University Voice Center, New York University School of Medicine, New York, New York

Send correspondence to Ryan C. Branski, PhD, NYU Voice Center, 345 East 37th Street, Suite 306, New York, NY 10016. E-mail: [email protected]Search for more papers by this author
Milan R. Amin MD

Milan R. Amin MD

Department of Otolaryngology–Head and Neck Surgery, New York University Voice Center, New York University School of Medicine, New York, New York

Search for more papers by this author
First published: 27 December 2017
Citations: 12

Portions of these data were submitted for consideration at the American Broncho-Esophageal Association/Combined Otolaryngology Spring Meetings, National Harbor, Maryland, U.S.A., April 18–20, 2018.

The authors have no funding, financial relationships, or conflicts of interest to disclose.

Abstract

Objectives/Hypothesis

To develop a clinically relevant model of oropharyngeal concurrent chemoradiation therapy (CCRT) in order to quantify the effects of CCRT on tongue function and structure. CCRT for advanced oropharyngeal cancer commonly leads to tongue base dysfunction and dysphagia. However, no preclinical models currently exist to study the pathophysiology of CCRT-related morbidity, thereby inhibiting the development of targeted therapeutics.

Study Design

Animal model.

Methods

Twenty-one male Sprague-Dawley rats were randomized into three groups: 2 week (2W), 5 month (5M), and control (C). The 2W and 5M animals received cisplatin, 5-fluorouracil, and five fractions of 7 Gy to the tongue base; the C animals received no intervention. In vivo tongue strength and displacement, as well as hyoglossus muscle collagen content, were assessed. Analyses were conducted 2 weeks or 5 months following completion of CCRT in the 2W and 5M groups, respectively.

Results

Peak tetanic and twitch tongue forces were significantly reduced in both 2W and 5M animals compared to controls (tetanic: P = .0041, P = .0089, respectively; twitch: P = .0201, P = .0020, respectively). Twitch half-decay time was prolonged in 2W animals compared to controls (P = .0247). Tongue displacement was significantly reduced across all testing parameters in 5M animals compared to both the C and 2W groups. No differences in collagen content were observed between experimental groups.

Conclusions

The current study is the first to describe a preclinical model of CCRT to the head and neck with an emphasis on clinical relevance. Tongue strength decreased at 2 weeks and 5 months post-CCRT. Tongue displacement increased only at 5 months post-CCRT. Fibrosis was not detected, implicating alternative causative factors for these findings.

Level of Evidence

NA Laryngoscope, 1783–1790, 2018

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.